Search Results - "Cagney, H."

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer by Stares, M., Ding, T.E., Stratton, C., Thomson, F., Baxter, M., Cagney, H., Cumming, K., Swan, A., Ross, F., Barrie, C., Maclennan, K., Campbell, S., Evans, T., Tufail, A., Harrow, S., Lord, H., Laird, B., MacKean, M., Phillips, I.

“…Pembrolizumab is an established first-line option for patients with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 ≥50%…”
Get full text

Strategies for producing high value small molecules in microalgae by Cagney, Michael H., O'Neill, Ellis C.

“…Eukaryotic microalgae are a diverse group of organisms that can be used for the sustainable production of a wide range of high value compounds, including…”
Get full text

The characteristics of a real-world Upper Gastrointestinal cancer population by Baxter, M., Cullen, M., Taylor, L., Cagney, H., Church, M., Steedman, P., Mccleary, E., Lord, H., Merrick, C., Petty, R.

Get full text